A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, investigators found that a single dose of…
New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer
